Inventor

WHITE JR RALPH L

9 patents

⚠️ This page may combine multiple inventors who share the name “WHITE JR RALPH L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MORTON NORWICH PRODUCTS INC

7 patents

US4137402AJan 30, 1979

Quaternary ammonium salts of dantrolene and clodanolene

MORTON NORWICH PRODUCTS INC22 citations81

US4049650ASep 20, 1977

1-[[[5-(Substituted phenyl)-2-oxazolyl]methylene]amino]-2,4-imidazolidinediones

MORTON NORWICH PRODUCTS INC8 citations71

US4001222AJan 4, 1977

3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof

MORTON NORWICH PRODUCTS INC7 citations71

US4273927AJun 16, 1981

NORWICH EATON PHARMA

2 patents

US4895867AJan 23, 1990

2-(5-phenyl-2-furanyl)imidazoles useful as cardiotonic agents

NORWICH EATON PHARMA9 citations70

US4861790AAug 29, 1989

Use of azumolene for the treatment of malignant hyperthermia

NORWICH EATON PHARMA4 citations57

WHITE JR RALPH L

MORTON NORWICH PRODUCTS INC

Quaternary ammonium salts of dantrolene and clodanolene

1-[[[5-(Substituted phenyl)-2-oxazolyl]methylene]amino]-2,4-imidazolidinediones

3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof

Converting enzyme inhibitor

1-(4-chlorophenyl)-3-(1-ureido)-2-imidazolidinone

1-Amino-3-(4-chlorophenyl)-2-imidazolidinone

2-Amino-5-phenylmethoxy-6-methoxybenzothiazole hydrochloride

NORWICH EATON PHARMA

2-(5-phenyl-2-furanyl)imidazoles useful as cardiotonic agents

Use of azumolene for the treatment of malignant hyperthermia